Safety evaluation of genipin in Beagle dogs: acute and 28-day repeated oral toxicity studies
Frontiers in Pharmacology · 30.10.2026 · 17
DOI: 10.3389/fphar.2026.1924890 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 30.10.2026. Verfasst von Qianchao Meng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Drug Safety Evaluation and Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Genipin, a typical iridoid constituent derived from the fruits of Gardenia jasminoides Ellis, is an essential in vivo metabolite of geniposide. It exhibits diverse potent biofunctions, including hepatoprotection, anti-inflammation, neuroprotection, antioxidation, and glycolipid metabolism modulation. Nevertheless, the systemic toxicological profile of genipin remains insufficiently characterized, with particularly limited safety evidence from non-rodent models. This study aimed to evaluate the acute and subacute oral toxicity of genipin in Beagle dogs as a preclinical safety assessment.
Methods
Acute toxicity was assessed using single oral doses of genipin at 29, 41, 59, 84, 120, and 140 mg/kg. For subacute toxicity, repeated-dose groups were administered 3, 9, and 27 mg/kg/day for 28 days. Clinical signs, body weight, food intake, hematology, clinical chemistry, urinalysis, electrocardiography, fecal occult blood, and histopathology were evaluated.
Results
The results showed that the oral approximate lethal dose of genipin was 120.0–140.0 mg/kg, with doses ≥41 mg/kg inducing thymic, hepatorenal, and gallbladder toxicity. Repeated 27 mg/kg/day genipin caused gastrointestinal irritation, anemia, prolonged coagulation parameters, and toxicity to the hepatobiliary system, thymus, bone marrow, and gonads; 3 and 9 mg/kg/day genipin induced mild male gonad toxicity. Bone marrow toxicity and gastric mucosal irritation were fully reversible after recovery, while hepatic, thymic, and gonadal toxicity showed partial recovery.
Conclusion
This study clarified the dose-toxicity relationship, major target organs, and toxic reversibility of genipin following oral exposure in non-rodent species. These findings provide robust preclinical toxicological evidence to support rational dosage optimization, risk assessment, and the safe use of genipin.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Drug Safety Evaluation and Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Zitieren
APA
Meng, Q., Sun, W., Kang, L., Huang, M., Wu, T., Gu, Y., Zhang, J., Cao, Z., Yang, F., & Yao, G. (2026). Safety evaluation of genipin in Beagle dogs: acute and 28-day repeated oral toxicity studies. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1924890
Vancouver
Meng Q, Sun W, Kang L, Huang M, Wu T, Gu Y, et al. Safety evaluation of genipin in Beagle dogs: acute and 28-day repeated oral toxicity studies. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1924890
BibTeX
@article{Meng2026,
author = {Meng, Qianchao and Sun, Wei and Kang, Lijing and Huang, Mingshu and Wu, Taofen and Gu, Yingmin and Zhang, Jianqiang and Cao, Zhili and Yang, Fei and Yao, Guangtao},
title = {Safety evaluation of genipin in Beagle dogs: acute and 28-day repeated oral toxicity studies},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.1924890}
}
EUVIMED